Anti-stroke biologics: from recombinant proteins to stem cells and organoids

The use of biologics in various diseases has dramatically increased in recent years. Stroke, a cerebrovascular disease, is the second most common cause of death, and the leading cause of disability with high morbidity worldwide. For biologics applied in the treatment of acute ischaemic stroke, altep...

Full description

Saved in:
Bibliographic Details
Main Authors: Shu-Na Wang, Chao-Yu Miao, Zhi Wang, Zhu-Wei Miao, Si-Li Zheng
Format: Article
Language:English
Published: BMJ Publishing Group
Series:Stroke and Vascular Neurology
Online Access:https://svn.bmj.com/content/early/2024/01/29/svn-2023-002883.full
Tags: Add Tag
No Tags, Be the first to tag this record!